2,3,6-Tri-O-methyl-beta-D-glucopyranose

Details

Top
Internal ID 6b7e85ac-c07d-4a73-9fa7-1ecc9cb50e0c
Taxonomy Organic oxygen compounds > Organooxygen compounds > Carbohydrates and carbohydrate conjugates > Monosaccharides > Hexoses
IUPAC Name (2R,3R,4S,5R,6R)-3,4-dimethoxy-6-(methoxymethyl)oxane-2,5-diol
SMILES (Canonical) COCC1C(C(C(C(O1)O)OC)OC)O
SMILES (Isomeric) COC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O)OC)OC)O
InChI InChI=1S/C9H18O6/c1-12-4-5-6(10)7(13-2)8(14-3)9(11)15-5/h5-11H,4H2,1-3H3/t5-,6-,7+,8-,9-/m1/s1
InChI Key LXJBARMBDDODTG-SYHAXYEDSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C9H18O6
Molecular Weight 222.24 g/mol
Exact Mass 222.11033829 g/mol
Topological Polar Surface Area (TPSA) 77.40 Ų
XlogP -1.50
Atomic LogP (AlogP) -1.26
H-Bond Acceptor 6
H-Bond Donor 2
Rotatable Bonds 4

Synonyms

Top
GU8
2,3,6-tri-O-methyl-beta-D-glucose; 2,3,6-tri-O-methyl-D-glucose; 2,3,6-tri-O-methyl-glucose

2D Structure

Top
2D Structure of 2,3,6-Tri-O-methyl-beta-D-glucopyranose

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption - 0.5600 56.00%
Caco-2 - 0.6861 68.61%
Blood Brain Barrier + 0.5750 57.50%
Human oral bioavailability + 0.5143 51.43%
Subcellular localzation Mitochondria 0.7665 76.65%
OATP2B1 inhibitior - 0.8566 85.66%
OATP1B1 inhibitior + 0.9058 90.58%
OATP1B3 inhibitior + 0.9234 92.34%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.9750 97.50%
BSEP inhibitior - 0.9542 95.42%
P-glycoprotein inhibitior - 0.9356 93.56%
P-glycoprotein substrate - 0.9620 96.20%
CYP3A4 substrate - 0.5533 55.33%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8209 82.09%
CYP3A4 inhibition - 0.9427 94.27%
CYP2C9 inhibition - 0.9196 91.96%
CYP2C19 inhibition - 0.8743 87.43%
CYP2D6 inhibition - 0.9137 91.37%
CYP1A2 inhibition - 0.9300 93.00%
CYP2C8 inhibition - 0.9305 93.05%
CYP inhibitory promiscuity - 0.9412 94.12%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 0.9100 91.00%
Carcinogenicity (trinary) Non-required 0.6382 63.82%
Eye corrosion - 0.9649 96.49%
Eye irritation - 0.8046 80.46%
Skin irritation - 0.8813 88.13%
Skin corrosion - 0.9692 96.92%
Ames mutagenesis - 0.7300 73.00%
Human Ether-a-go-go-Related Gene inhibition - 0.4607 46.07%
Micronuclear - 0.7526 75.26%
Hepatotoxicity - 0.6449 64.49%
skin sensitisation - 0.8943 89.43%
Respiratory toxicity - 0.8556 85.56%
Reproductive toxicity - 0.6000 60.00%
Mitochondrial toxicity - 0.7500 75.00%
Nephrotoxicity - 0.6191 61.91%
Acute Oral Toxicity (c) III 0.6552 65.52%
Estrogen receptor binding - 0.8084 80.84%
Androgen receptor binding - 0.8021 80.21%
Thyroid receptor binding + 0.5484 54.84%
Glucocorticoid receptor binding - 0.7213 72.13%
Aromatase binding - 0.7771 77.71%
PPAR gamma - 0.7288 72.88%
Honey bee toxicity - 0.8871 88.71%
Biodegradation - 0.6750 67.50%
Crustacea aquatic toxicity - 0.6034 60.34%
Fish aquatic toxicity - 0.8434 84.34%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 95.66% 96.09%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 88.77% 91.11%
CHEMBL226 P30542 Adenosine A1 receptor 87.81% 95.93%
CHEMBL253 P34972 Cannabinoid CB2 receptor 85.00% 97.25%
CHEMBL3401 O75469 Pregnane X receptor 80.79% 94.73%

Cross-Links

Top
PubChem 448683
NPASS NPC267887